@ChoiceChoi3 Choice Choi

Choice Choi posts on X about $nnox, $nanox, ai, ceo the most. They currently have [---] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

Engagements: [-----] #

[--] Week [---] +3.80%
[--] Month [-----] -46%
[--] Months [------] +1,217%
[--] Year [------] +40%

Mentions: [--] #

[--] Week [--] no change
[--] Month [--] +180%
[--] Months [---] +918%
[--] Year [---] +122%

Followers: [---] #

[--] Week [---] +0.32%
[--] Month [---] +0.21%
[--] Months [---] +3.20%
[--] Year [---] +5.40%

CreatorRank: [---------] #

Social Influence

Social category influence stocks 86.07% finance 13.93% countries 8.2% technology brands 4.1% exchanges 0.82%

Social topic influence $nnox #1, $nanox #1, ai 17.21%, ceo 8.2%, $nanoxarc #1, business 5.74%, $nnoxs 4.92%, in the 4.1%, israel 2.46%, health 2.46%

Top accounts mentioned or mentioned by @thejape123 @steveleeesq

Top assets mentioned Nano-X Imaging Ltd. (NNOX) Microsoft Corp. (MSFT) Intuitive Surgical, Inc. (ISRG)

Top Social Posts

Top posts by engagements in the last [--] hours

"Finally $NANOX officially announced its offline participation in #RSNA. It has been a long time since I decided to invest in $NNOX. The reason why I chose it as a retirement item is because the founder suddenly died of liver cancer amid suspicions of scams due to numerous bad reviews malicious criticism and responsibility that was not shown in time It is also because I visited Yongin Fab twice in [----] and [----] and confirmed the actual operation of the cold cathode but it is also because I recognized the reality that many people who were fighting for their lives during the pandemic and"
X Link 2024-11-14T01:32Z [---] followers, 15.7K engagements

"$NNOX $NANOX This is the world's most advanced X-ray source revolution and the evidence silences its critics. It's all true and I'm basing it on facts. This is the world's most advanced X-ray source revolution and the evidence that silences its critics. It's all true and it's based on facts. And that's not even all. It's just a part of it. https://twitter.com/i/web/status/2003438354873069641 https://twitter.com/i/web/status/2003438354873069641"
X Link 2025-12-23T12:11Z [---] followers, [----] engagements

"$NANOX Arc-X RSNA [----] $NNOX https://www.linkedin.com/posts/nanox-imaging_rsna-nanoxarcx-imaginginnovation-activity-7401301475697795072-aJT9utm_source=share&utm_medium=member_android&rcm=ACoAAByPfuMBdE3-s0MWPxniC2GKHabPx7busGY https://www.linkedin.com/posts/nanox-imaging_rsna-nanoxarcx-imaginginnovation-activity-7401301475697795072-aJT9utm_source=share&utm_medium=member_android&rcm=ACoAAByPfuMBdE3-s0MWPxniC2GKHabPx7busGY"
X Link 2025-12-01T17:07Z [---] followers, [---] engagements

"$NANOX Arc-X $NNOX RSNA 2025"
X Link 2025-12-01T17:11Z [---] followers, [---] engagements

"The new $NANOX Arc-X glass tube has finally been revealed $NNOX"
X Link 2025-12-01T18:37Z [---] followers, [----] engagements

"$NANOX Arc-X Cold Cathode Emitter Glass enveloped Tube. $NNOX"
X Link 2025-12-01T18:43Z [---] followers, [----] engagements

"Just Renewaled $NNOX Arc_X website. https://www.nanox.vision/nanox-arcx/ https://www.nanox.vision/nanox-arcx/"
X Link 2025-12-02T02:53Z [---] followers, [----] engagements

"From Vision to Reality AI and Digital Tomosynthesis in Pulmonary Nodule Detection $NNOX ArcX 3D tomosynthesis $NANOX AI https://www.linkedin.com/posts/nanox-imaging_starting-at-1100-am-today-join-orit-wimpfheimer-activity-7401653553133637632-HSmNutm_source=share&utm_medium=member_desktop&rcm=ACoAAByPfuMBdE3-s0MWPxniC2GKHabPx7busGY https://www.linkedin.com/posts/nanox-imaging_starting-at-1100-am-today-join-orit-wimpfheimer-activity-7401653553133637632-HSmNutm_source=share&utm_medium=member_desktop&rcm=ACoAAByPfuMBdE3-s0MWPxniC2GKHabPx7busGY"
X Link 2025-12-02T17:31Z [---] followers, [----] engagements

"2025 RSNA Day [---] $NANOX Arc-X reviewed by #RadiologyBusiness $NNOX https://www.linkedin.com/posts/radiology-business_rsna2025-activity-7401814103868284928-WDQNutm_source=share&utm_medium=member_desktop&rcm=ACoAAByPfuMBdE3-s0MWPxniC2GKHabPx7busGY https://www.linkedin.com/posts/radiology-business_rsna2025-activity-7401814103868284928-WDQNutm_source=share&utm_medium=member_desktop&rcm=ACoAAByPfuMBdE3-s0MWPxniC2GKHabPx7busGY"
X Link 2025-12-03T04:52Z [---] followers, [----] engagements

"Wonder I am. $NANOX Arc-X and multi beam array #Varexs enveloped glass tube $NNOX Mems Chip https://www.linkedin.com/posts/radiology-business_rsna2025-activity-7401804644962009088-fIzcutm_source=share&utm_medium=member_desktop&rcm=ACoAAByPfuMBdE3-s0MWPxniC2GKHabPx7busGY https://www.linkedin.com/posts/radiology-business_rsna2025-activity-7401804644962009088-fIzcutm_source=share&utm_medium=member_desktop&rcm=ACoAAByPfuMBdE3-s0MWPxniC2GKHabPx7busGY"
X Link 2025-12-03T05:35Z [---] followers, [----] engagements

"$NANOX Arc-X $NNOX https://www.linkedin.com/posts/rsna-nanoxarcx-nanoxai-ugcPost-7402018907353632768-1QNLutm_source=share&utm_medium=member_android&rcm=ACoAAByPfuMBdE3-s0MWPxniC2GKHabPx7busGY https://www.linkedin.com/posts/rsna-nanoxarcx-nanoxai-ugcPost-7402018907353632768-1QNLutm_source=share&utm_medium=member_android&rcm=ACoAAByPfuMBdE3-s0MWPxniC2GKHabPx7busGY"
X Link 2025-12-03T20:41Z [---] followers, [---] engagements

"$NANOX Arc-X $NNOX https://www.linkedin.com/posts/tv-radiology_rsna-imaging-radiology-ugcPost-7402679888777785345-zR4hutm_source=share&utm_medium=member_android&rcm=ACoAAByPfuMBdE3-s0MWPxniC2GKHabPx7busGY https://www.linkedin.com/posts/tv-radiology_rsna-imaging-radiology-ugcPost-7402679888777785345-zR4hutm_source=share&utm_medium=member_android&rcm=ACoAAByPfuMBdE3-s0MWPxniC2GKHabPx7busGY"
X Link 2025-12-05T15:21Z [---] followers, [---] engagements

"$Nanox.ARC - X $NNOX Cold Cathode with breakthrough imaging technology"
X Link 2025-12-05T15:27Z [---] followers, [----] engagements

"What I learned during the $NNOX feasibility study Despite the complete lack of recognition for 2D CXR as a equip for early "lung cancer screening" approximately "33 million" cases are being performed annually wasting valuable funds. When $NANOX receives #TAP2D approval and becomes a standalone device the #Arc-X will creates a significant contribution while also reducing the cost of duplicate scans. Even in terms of CapEx the 3D tomosynthesis Arc-X including end-to-end services was found to be cheaper than the 2D CXR equipment + options. https://twitter.com/i/web/status/1998707858985353671"
X Link 2025-12-10T10:54Z [---] followers, [----] engagements

"$Nanox.ARC - X $NNOX [----] RSNA"
X Link 2025-12-11T13:25Z [---] followers, [----] engagements

"After completing field testing and clinical validation of product lineup (durability - performance degradation defense mechanisms) $NANOX appear to be beginning full-scale marketing and promotion. $NNOX #Arc-X Tube (and Chip) OEM - All Industries AI Solutions Three years late to launch but three years early It will dominate the global market. https://youtu.be/EIyAmEzgU4Ifeature=shared https://youtu.be/EIyAmEzgU4Ifeature=shared"
X Link 2025-12-16T13:03Z [---] followers, [----] engagements

"$NNOX $NANOX"
X Link 2025-12-23T11:43Z [---] followers, [----] engagements

"$NNOX $NANOX TAP2D superiority"
X Link 2025-12-23T11:58Z [---] followers, [----] engagements

"$NNOX 4Q $NANOX -. In India Skanray Arc . -. In Italia CEI glass tube field test. -. Varex glass tube field test & Soft tissue Application. -. OEM. -. OEM . -. [--] Soft Tissue . Israel Review. -. USA shipping Training Center . -. CE mark Technical Report (_ Application_). -. Initial Deployment . -. [--] . -. Time Square Nasdaq [--] [--] Investor's day"
X Link 2023-11-16T11:57Z [---] followers, [----] engagements

"Those who spent years claiming " $NNOX MEMS doesn't work" are now watching #Varex integrate it into their flagship platform while their preferred CNT technology faces FDA scrutiny. The silence from the critic camp speaks volumes"
X Link 2025-12-22T03:01Z [---] followers, [----] engagements

"Although $Nanox has yet to officially announce its Mammo market entry allowing its many critics to see the truth having studied $NNOX for over five years I can confidently present the table below with sufficient evidence and facts. Nanox's mammography/DBT market entry is strategically feasible. Cold Cathode Multi-Source Technology provides an exclusive competitive advantage that major OEMs cannot replicate. Direct MSaaS + OEM Partnership Hybrid Strategy. This clearly demonstrates that management is already preparing for explosive growth in addition to exponential growth in Q3 2025."
X Link 2025-12-23T11:41Z [---] followers, [----] engagements

"$NNOX [----] Full Year Guidance: $35M Based on the "Pre-Orders". #Arc-X mass production: hundreds of units are in progresses #IntuitiveSurgical was once a penny stock too. Now The undisputed king of robotic surgery. What they share: Multi-year manufacturing partnership with #FABRINET Precision robotics engineering capability Penny stock Market dominator The #ISRG story. The $NNOX story in progress. History rhymes. https://twitter.com/i/web/status/2003777968376836324 https://twitter.com/i/web/status/2003777968376836324"
X Link 2025-12-24T10:41Z [---] followers, [----] engagements

"$NNOX $NANOX AI https://investors.nanox.vision/events/event-details/second-quarter-2023-financial-and-operating-results/ https://investors.nanox.vision/events/event-details/second-quarter-2023-financial-and-operating-results/"
X Link 2023-08-04T02:18Z [---] followers, [---] engagements

"Short to $NANOX $NNOX"
X Link 2023-08-07T13:43Z [---] followers, [----] engagements

"$NANOX AI $NNOX https://www.linkedin.com/posts/nanox-ai_nanoxaibone-solution-can-automatically-activity-7094995760949149697-Nczfutm_source=share&utm_medium=member_android https://www.linkedin.com/posts/nanox-ai_nanoxaibone-solution-can-automatically-activity-7094995760949149697-Nczfutm_source=share&utm_medium=member_android"
X Link 2023-08-09T11:56Z [---] followers, [----] engagements

"Market shares of diagnostics imaging $NNOX could be reaches 5% in global within 34years. $NANOX aims early detection in public health"
X Link 2023-08-10T13:14Z [---] followers, [----] engagements

"In an additional step toward optimizing $NNOX mass manufacturing capabilities $NANOX have initiated collaboration with Skanray for Nanox.ARC systems assembly at scale"
X Link 2023-08-18T12:07Z [---] followers, [----] engagements

"Florida center for commercial purposes. The first $NNOX.ARC system was shipped from Israel and arrived in the U.S. for installation in the clinical site which $NANOX expect to open the clinical site during the fourth quarter of this year. Based on market analysis of the U.S. market of clinicians imaging administrators and directors stakeholders recognized the clinical benefits of the Nanox.ARC and its more affordable approach to advanced imaging techniques. https://twitter.com/i/web/status/1692509500199301301 https://twitter.com/i/web/status/1692509500199301301"
X Link 2023-08-18T12:11Z [---] followers, [----] engagements

"$NNOX $NANOX Profitability Improvement. Numerous uncertainties has been resolved. In addition the price is absolutely attractive. The intrinsic value is now too much underrated. Buy the dip"
X Link 2023-08-18T15:05Z [---] followers, [----] engagements

"$NNOX'S partner of one for mass production. -. CEI : Digitalized glass tube. -. Skanray : $NANOX Arc DTs and 2D XDR vertical and further more C-Arm flouroscopy. Impressive same slogan; "Nothing is Opaque ""
X Link 2023-08-22T12:57Z [---] followers, [----] engagements

"$NANOX AI $NNOX https://www.linkedin.com/feed/update/urn:li:activity:7092104199508783104utm_source=share&utm_medium=member_android https://www.linkedin.com/feed/update/urn:li:activity:7092104199508783104utm_source=share&utm_medium=member_android"
X Link 2023-08-28T07:36Z [---] followers, [---] engagements

"$NANOX $NNOX https://www.fool.com/investing/2023/08/28/3-magnificent-growth-stocks-to-buy-on-the-dip/source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article https://www.fool.com/investing/2023/08/28/3-magnificent-growth-stocks-to-buy-on-the-dip/source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article"
X Link 2023-08-28T13:32Z [---] followers, [----] engagements

"$NNOX management confirmed that they are doing focus on Arc deployment to the several regions. Management is willing to host small group of delegations to check what $NANOX are doing"
X Link 2023-08-30T12:49Z [---] followers, [----] engagements

"$NANOX #BVGH $NNOX Both parties will host 2nd seminar. BIO Ventures for Global Health and NANO-X IMAGING invite you to attend this free digital lecture series focused on strengthening radiologists capacities in diagnostic imaging performance patient safety and image interpretation led by expert trainers from Emory University NANO-X IMAGING Memorial Sloan Kettering Cancer Center and Penn Medicine presented through Zoom. https://us02web.zoom.us/webinar/register/WN_LvjTkvFpS6mPJZbHke_wDw#/registration https://us02web.zoom.us/webinar/register/WN_LvjTkvFpS6mPJZbHke_wDw#/registration"
X Link 2023-08-30T12:54Z [---] followers, [----] engagements

"$NNOX $NANOX https://www.linkedin.com/posts/hwan-hwan-930986222_%EC%96%B4%EB%8B%9D%EC%BD%9C%EC%97%90%EC%84%9C-erez-meltzer-ceo%EB%8A%94-%EB%8C%80%EB%9F%89-%EC%A0%9C%EC%A1%B0-%EB%8A%A5%EB%A0%A5%EC%9D%84-%EC%B5%9C%EC%A0%81%ED%99%94%ED%95%98%EA%B8%B0-%EC%9C%84%ED%95%9C-activity-7102242011348434944-lV6Nutm_source=share&utm_medium=member_android"
X Link 2023-08-30T23:49Z [---] followers, [---] engagements

"CEO confirmed that they are focuses on marketing the US market $NANOX aim is to strategically engage segments that show early adoption potential such as orthopedic clinics skilled nursing facility freestanding emergency departments and urgent care facilities. [--]. Nursing Homes: [-----] locations [--]. Skilled Nursing Clinics (professional nursing rehabilitation hospitals): [-----] locations (as of March 2023) [--]. Assisted Living Facilities: [-----] locations (as of April 2023) [--]. Freestanding emergency departments (private emergency hospitals): [--]. Urgent care facilities (emergency centers): 10800"
X Link 2023-08-31T09:24Z [---] followers, [---] engagements

"$NNOX CEO confirmed that they are focuses on marketing in the US market. $NANOX aim is to strategically engage segments that show early adoption potential such as orthopedic clinics skilled nursing facility freestanding emergency departments and urgent care facilities. [--]. Nursing Homes: [-----] locations [--]. Skilled Nursing Clinics (professional nursing rehabilitation hospitals): [-----] locations (as of March 2023) [--]. Assisted Living Facilities: [-----] locations (as of April 2023) [--]. Freestanding emergency departments (private emergency hospitals): [--]. Urgent care facilities (emergency centers):"
X Link 2023-08-31T10:58Z [---] followers, [----] engagements

"$NNOX Arc $NANOX AI https://www.linkedin.com/posts/nanox-imaging_nanox-nanoxarc-medicalimaging-activity-7105896368006647809-XnJvutm_source=share&utm_medium=member_android https://www.linkedin.com/posts/nanox-imaging_nanox-nanoxarc-medicalimaging-activity-7105896368006647809-XnJvutm_source=share&utm_medium=member_android"
X Link 2023-09-08T13:15Z [---] followers, [----] engagements

"$NNOX $NANOX https://investors.nanox.vision/news-releases/news-release-details/nanox-present-cantor-fitzgerald-global-healthcare-conference-0/ https://investors.nanox.vision/news-releases/news-release-details/nanox-present-cantor-fitzgerald-global-healthcare-conference-0/"
X Link 2023-09-13T13:14Z [---] followers, [----] engagements

"$NNOX $NANOX https://www.linkedin.com/posts/nanox-imaging_nanox-investorrelations-firesidechat-activity-7110601644995731457-ZVz3utm_source=share&utm_medium=member_android https://www.linkedin.com/posts/nanox-imaging_nanox-investorrelations-firesidechat-activity-7110601644995731457-ZVz3utm_source=share&utm_medium=member_android"
X Link 2023-09-21T12:53Z [---] followers, [----] engagements

"$NANOX $NNOX https://investors.nanox.vision/news-releases/news-release-details/nanox-host-investor-day-october-17-2023 https://investors.nanox.vision/news-releases/news-release-details/nanox-host-investor-day-october-17-2023"
X Link 2023-10-02T13:52Z [---] followers, [---] engagements

"$NNOX it's a huge. We are pleased to announce our manufacturing and supply agreement with $Nanox. This agreement reflects our belief in the future importance of cold cathode technology said Sunny Sanyal Chief Executive Officer of #Varex Imaging. Sanyal added Together we aim to advance medical imaging technology reduce costs and make a meaningful impact on global healthcare. We look forward to a fruitful and innovative journey ahead."
X Link 2023-10-03T13:10Z [---] followers, [----] engagements

"$NANOX $NNOX https://www.americanbankingnews.com/2023/10/04/nano-x-imagings-nnox-overweight-rating-reaffirmed-at-cantor-fitzgerald.html https://www.americanbankingnews.com/2023/10/04/nano-x-imagings-nnox-overweight-rating-reaffirmed-at-cantor-fitzgerald.html"
X Link 2023-10-04T10:18Z [---] followers, [---] engagements

"$NNOX business in particular our US operations and go to market strategy continue as planned and $Nanox employees are working safely as we continue to monitor and adapt to the evolving situation. We will continue to monitor the situation and provide updates as necessary. We plan to announce the new date for the Investor Day and provide additional information in the coming weeks. https://investors.nanox.vision/news-releases/news-release-details/nanox-continues-business-planned-and-postpones-investor-day/"
X Link 2023-10-10T14:06Z [---] followers, [----] engagements

"Microsoft-Bill & Melinda Gates foundation could be . $NNOX Arc $NANOX AI innovative products. $nnox https://t.co/l2k7dmUbgp in partnership with Nuance Communications & Microsoft Microsoft Azure invites you to join our online webinar Using Al to assess coronary artery calcification on October [--] at [--] pm ET. https://t.co/7ZytKqwWbx https://t.co/Hm7FGq9Z2u $nnox https://t.co/l2k7dmUbgp in partnership with Nuance Communications & Microsoft Microsoft Azure invites you to join our online webinar Using Al to assess coronary artery calcification on October [--] at [--] pm ET. https://t.co/7ZytKqwWbx"
X Link 2023-10-10T14:47Z [---] followers, [----] engagements

"$NNOX $NANOX AI partnership #Nuance #Microsoft Azure will host online Webinar. https://www.linkedin.com/posts/nanox-ai_healthcaretech-ai-radiology-activity-7117489416046043139-U001utm_source=share&utm_medium=member_android https://www.linkedin.com/posts/nanox-ai_healthcaretech-ai-radiology-activity-7117489416046043139-U001utm_source=share&utm_medium=member_android"
X Link 2023-10-11T11:42Z [---] followers, [----] engagements

"$NANOX AI Cardiac solution in the News empowering data to improve healthcare. $NNOX AI HealthCCSng algorithm identified moderate to severe level of coronary artery calcium (CAC) in 58% of patients. https://youtu.be/3oS34IeRYiYsi=0Pglmy_mo1_yB8PI https://youtu.be/3oS34IeRYiYsi=0Pglmy_mo1_yB8PI"
X Link 2023-10-16T13:21Z [---] followers, [----] engagements

"$Nanox to Report Third Quarter [----] Financial Results on November [--] [----] and Reschedules Investor Day for December [--] [----] November [--] [----] 09:00 ET Source:Nano-X Imaging LTD.Follow NEVE ILAN Israel Nov. [--] [----] (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: $NNOX) (Nanox or the Company) an innovative medical imaging technology company today announced that it will report its financial results for the quarter ended September [--] [----] on November [--] [----] at 8:30 a.m. ET. The Company also announced that it will hold its Investor Day on December [--] [----] at the Nasdaq building in New York City."
X Link 2023-11-09T14:26Z [---] followers, [----] engagements

"$NANOX $NNOX disclosed 3rd Quarter ER. https://www.globenewswire.com/news-release/2023/11/28/2786909/0/en/Nanox-Announces-Third-Quarter-of-2023-Financial-Results-and-Provides-Business-Update.html https://www.globenewswire.com/news-release/2023/11/28/2786909/0/en/Nanox-Announces-Third-Quarter-of-2023-Financial-Results-and-Provides-Business-Update.html"
X Link 2023-11-28T13:30Z [---] followers, [----] engagements

"Nanox Investor Day4th December in New York. $NNOX disclosed that agenda of Investor Day. Key 🔑 would be the average of "scan per day" $NANOX Arc. And insurer's reimbursement to candidates customers in the market. Let's take a look agenda carefully. so exciting 😊"
X Link 2023-11-30T06:46Z [---] followers, [----] engagements

"$NANOX $NNOX Investor Day in New York [----]. It's the initial trajectory of regional regulatory"
X Link 2023-12-04T13:53Z [---] followers, [----] engagements

"$NANOX $NNOX disclosed that scan per day in Morocco. "Morocco is getting 15-20 scans per day.""
X Link 2023-12-04T14:22Z [---] followers, [----] engagements

"Hopefully That's be the answer for you what $NANOX done. : AI solution $NNOX Silent Killer: $NNOX has ultra-low-cost AI diagnostic solutions for chronic diseases such as lung disease fatty liver etc. ------- How common is fatty liver disease in the US In the United States the prevalence of fatty liver disease ranges from10-46% and liver biopsy based studies report a prevalence of NASH of 1-17%. Systematic reviews suggest NAFLD prevalence in adults is probably 25-33% while NASH prevalence is 2-5%. https://twitter.com/i/web/status/1757115419708801472"
X Link 2024-02-12T18:52Z [---] followers, [---] engagements

"Since the IPO in August [----] Moving forward one step at a time Investors are getting closer to the $NNOX business portfolio vision of early diagnosis of chronic diseases (lung abdomen). Next $NANOX would 3D DE- DT Arc's CE including Soft_Tissue and FDA"
X Link 2024-02-14T17:27Z [---] followers, [----] engagements

"The case $NANOX IMO which caused a drop in stock prices and suspicions of a scheme ended with a settlement of $8 million compensating the victims' losses even though it was proven that the $NNOX technology developed over a long period of time that was not a fraud. Out of respect for the deceased I refrain from criticizing Great Founder Ran Poliakin. It is left as a key highlight scene that I remember and it should be resolved that uncertainty through the dark tunnel of investment for a long time since IPO. Now the $NANOX would become an unrivaled leader in All Kind of Xray Modalities and"
X Link 2024-02-17T00:36Z [---] followers, [---] engagements

"@TheJape123 @steveleeesq For $NANOX and $NNOX'S investors. Criminal and civil retribution must begin"
X Link 2024-02-18T01:33Z [---] followers, [---] engagements

"Looking at the correlation between the quantity of deployment and the quantity of order $NANOX tubes the most accurate prediction is possible Even there seems to be a 50/50 chance that hundreds of units for $NNOX 3D Arc will be ordered at a time in [----] but performance is expected in several areas where OEM or performance testings are in progresses. Once the evaluation of that field tests are completed I expect that news of expansion of the MSaaS ecosystem will be released. IMO "NANOX DEMO" development tool kit which was first released on Last Investor Day in [----] it will be introduced to"
X Link 2024-02-26T11:11Z [---] followers, [----] engagements

"$NNOX Today $NANOX will have a open demonstrating commercial Arc at the New Jersey Demonstration Center. After the demonstration there will be a round table meeting with big investors and questions and information sharing for about two hours. There will be a total of [--] attendees and this meeting was a success as the company gladly accepted the request of the individual investor's group. https://twitter.com/i/web/status/1778043074775826686 https://twitter.com/i/web/status/1778043074775826686"
X Link 2024-04-10T12:51Z [---] followers, [----] engagements

"$NNOX $NANOX The environment for an open demonstration place is approved by the FDA and New Jersey State yesterday. It was: A patient who is well aware of his lesion and visits simultaneously with several radiologists It was a situation where deception could never work It was carried out in a state where no tricks or deception were tolerated. The results were very good and FACT reported that even areas that were difficult to detect with CT were discovered. https://twitter.com/i/web/status/1778331771437985929 https://twitter.com/i/web/status/1778331771437985929"
X Link 2024-04-11T07:58Z [---] followers, [----] engagements

"Please exploring that technique evidence which is approved by FDA and proven by IEC's conformance tests. $NANOX Arc deployment could be the simplified solutions of these global issues. It's lowered to 1/3045 Significantly reduces energy consumption. $NNOX granted multi source 501k. https://twitter.com/i/web/status/1782958625662837184 https://twitter.com/i/web/status/1782958625662837184"
X Link 2024-04-24T02:23Z [---] followers, [----] engagements

"$NNOX Business Model doesnt changed on the form of 20-F SEC. However according to market demands they are in the full of pride and more sophisticated and flexible to meet customer demands. $NANOX plan to commercialize X-ray source technology through three simultaneous business models: (i)Subscription Model (ii)CapEx Model (sales) (iii)Licensing Model for OEM. $NNOX expect the Subscription Model to be NANOXs primary business model for the X-ray source technology and the key vehicle to achieving business vision of increasing early detection of medical conditions that are discoverable by X-ray."
X Link 2024-04-24T12:17Z [---] followers, [----] engagements

"$NNOX CEO 4q ER We don't have a second chance to make a first impression especially not in the U.S. So we are installing the systems. We are analyzing the data. It is believed that the company has achieved the quality that determines the first impression of $NANOX"
X Link 2024-05-01T13:56Z [---] followers, [----] engagements

"Coming soon next $NNOX Arc X will submitted new FDA plug and play [--] day installation. It will unveiled on the $NANOX website soon"
X Link 2024-08-20T12:57Z [---] followers, [----] engagements

"$NNOX $NANOX 2q earnings call conference. CEO Erez Meltzer shows that . Visible vision of regulatory approval full_body CE & FDA. Touchable vision of full_body insurance reimbursement"
X Link 2024-08-20T14:09Z [---] followers, [----] engagements

"@TheJape123 Since IPO I haven't lost the optimistic positive to the $NANOX $NNOX"
X Link 2024-08-20T18:31Z [---] followers, [---] engagements

"$NNOX reports that MSK Clinical Trials Result. MSK Clinical Trial at Shamir Hospital has been completed demonstrating that $Nanox Arc is a valuable tool in the hospitals clinical workflow. The system enables faster diagnosis compared to standard x-ray systems. Diagnostic quality of the $NNOX Arc images was rated as excellent across all and has the potential to provide greater diagnostic accuracy. It has the potential to eliminate the need for CT while reducing radiation dose and costs."
X Link 2024-08-21T02:42Z [---] followers, [----] engagements

"Based on 2Q ER Summary of the main agendas that $NNOX is currently focusing on and an analysis of optimism and pessimism regarding them: -. Expanding the commercialization of the $Nanox.ARC system Currently deployed in [--] states in the US with [--] promising customers and [--] potential customers 510k submission to the FDA for expansion of general tomosynthesis imaging applications (included Chest) Optimism: Commercialization will accelerating and market expansion is likely upon FDA approval Pessimism: It may take more time until actual sales and monetization -. Development and integration of"
X Link 2024-08-29T01:34Z [---] followers, [----] engagements

"While CE Certification stand upon "advanced stage" $NNOX has publicly disclosed its FDA submission for Chest - Full body their existing model while also announcing plans for a future FDA application for the new $Nanox Arc-X. The Arc-X is purported to combine impeccable quality with cost-effectiveness and operational simplicity emphasizing early detection of chronic diseases. Here's a strategic analysis of this development: Phased Regulatory Approach:The sequential FDA submissions indicate a strategic phased approach to regulatory approval potentially mitigating risks and allowing for"
X Link 2024-08-30T10:17Z [---] followers, [----] engagements

"A brief of Cantor Fitzgerald virtual conference 18_09_2024 $NNOX vol [--]. - Company developed a special chip that uses Nano X-ray cold beam technology. - Chip is part of an $NANOX Arc system that aims to transform the world from 2D and 3D. - Technology was initially developed by Sony a media company. $Nanox: End-to-End Solution for Medical Imaging - Nanox developed an Arc system that scans patients and creates 3D images using [--] images from [--] tubes. - Arc provides both X-ray and CT images offering a comprehensive view of the patient's anatomy. - It aims to provide an end-to-end solution for"
X Link 2024-09-18T16:01Z [---] followers, [----] engagements

"Congratulations New era of AI powered 3D tomosynthesis. $NNOX $NANOX Let's check it out. https://www.nasdaq.com/marketsite/bell-ringing-ceremony https://www.nasdaq.com/marketsite/bell-ringing-ceremony"
X Link 2024-09-20T19:40Z [---] followers, [----] engagements

"Key Reasons Why $NANOX Conducts Promotional Marketing Before Grant "CE Certification". -------------------------------------------------- $NNOX s Medica Messe participates in the process because it is a major international medical technology trade fair and it provides a platform for companies like Nanox to showcase their innovations even if they are still awaiting CE certification. There maybe a few reasons for this: Brand Building and Awareness: Medica is a key venue for getting noticed by industry leaders even before official certifications are granted. Market Feedback: Displaying products"
X Link 2024-11-12T00:38Z [---] followers, [----] engagements

"3Q ER key agendas. $NNOX $NANOX Arc Expanding Medical Imaging Accessibility - Commitment to making advanced medical imaging accessible and affordable worldwide. - Positive public feedback and transformative potential of the solution. - Working with regulatory bodies to secure necessary approvals and expand market position. AI Solutions in Medical Imaging - Demonstrating the clinical utility and development of AI solutions in medical imaging. - Prioritizing clinical leads and development efforts to enhance robot clinical performance. - Ensuring innovations are advanced and relevant setting new"
X Link 2024-11-21T14:43Z [---] followers, [----] engagements

"This is an informative lecture on the advancements and applications of $NNOX Digital Tomosynthesis technology. Dr. Greg Kitka highlights how $NANOX technology can contribute to patient care through high resolution low dose imaging. Through a variety of clinical examples he demonstrates how it can eliminate structural noise a traditional drawback and enable accurate diagnosis. This lecture will give physicians the opportunity to understand the latest in digital tomosynthesis technology and how it can increase the value of their practice to their patients. In essence this content aims to"
X Link 2024-11-26T06:44Z [---] followers, [----] engagements

"I will review it in more detail based on filed report of 510k $NNOX Arc soon. $Nanox will create a public healthcare and early detection market. $NNOX $NANOX ARC Receives FDA Clearance for General Use Including Pulmonary Indication. https://t.co/76Rz6Ryktg $NNOX $NANOX ARC Receives FDA Clearance for General Use Including Pulmonary Indication. https://t.co/76Rz6Ryktg"
X Link 2024-12-05T11:40Z [---] followers, [----] engagements

"The early detection ability of 3mm nodules in the pulmonary has verified through clinical data for FDA review of $NNOX Arc's 3D Tomosynthesis. Analysis and Outlook of 3mm Lung Nodule Detection by $NANOX Arc [--]. Clinical Accuracy Analysis Evaluation of Diagnostic Accuracy Improved detection rate of nodules smaller than 3mm compared to existing 2D images Minimized unnecessary follow-up tests by reducing false positives Improved ability to characterize nodule shape and location Improved accuracy in distinguishing solid and semisolid nodules Increased accuracy in 3D location determination through"
X Link 2024-12-09T03:05Z [---] followers, [----] engagements

"$NNOX 3D Tomosynthesis FDA 510k regulatory approval has been registered; k242395 $Nanox.ARC"
X Link 2024-12-09T12:21Z [---] followers, [----] engagements

"Meaning of $Nanox.ARC's ECR [----] Abstract Acceptance $NNOX ## [--]. ECR's Status and Importance ### Conference Characteristics [--]. Europe's Largest Radiological Congress - Attendees: 30000+ professionals - Participating Countries: 100+ - Abstract Acceptance Rate: 30% - Impact Factor: Top 5% [--]. Technology Trend Leadership - New Technology Presentation Platform - Clinical Guideline Setting - Industry Standard Influence - Regulatory Authority Reference ### Scientific Impact [--]. Academic Value - Peer-reviewed validation - Clinical evidence presentation - Research methodology verification -"
X Link 2025-01-13T13:48Z [---] followers, [----] engagements

"$NNOX $NANOX MSaaS fast growing market perspective. # 3D Tomosynthesis Market Segmentation Analysis (Total $12B/year with DBT) ## Application Segment Analysis 3D Tomosynthesis market is primarily segmented by medical applications with breast imaging dominating the landscape. The market distribution across applications is as follows: Breast Imaging (65% market share): Demonstrates superior performance in early detection and reduction of false positives maintaining its position as the primary application domain. The segment shows consistent growth driven by increasing adoption in screening"
X Link 2025-01-23T06:39Z [---] followers, [----] engagements

"$NNOX Vision's [--] abstracts accepted into ECR [----] - Highlighting evidence supporting value of $Nanox.ARC and digital tomosynthesis - Opportunity to showcase Nanox's innovative technology at prestigious radiology congress - Aim to network with potential partners/customers in Europe ECR [----] attendees can schedule 1-on-1 meetings to learn more about Nanox Vision and its transformative medical imaging solutions. I believe this promotional information is a great reward for long-term investors who have observed technology development over the past four and a half years."
X Link 2025-01-28T10:36Z [---] followers, [----] engagements

""Strategic Market Analysis: $NNOX's Integration into Chronic Disease Management" Market Overview and Strategic Position: $Nanox is strategically positioning itself within the chronic disease management sector which represents one of healthcare's most substantial and rapidly expanding markets. The company's approach aligns with critical public health challenges in managing chronic conditions including: Key Disease Categories by Prevalence: [--]. Cardiovascular Diseases - Hypertension - Coronary Artery Disease - Stroke - Heart Failure [--]. Respiratory Diseases - COPD - Asthma - Lung Cancer 3."
X Link 2025-01-31T13:21Z [---] followers, [----] engagements

"$NANOX.ARC superiority. $NNOX low dose mili second pulsation stitching. In the Acquisition method of implementing 3D tomosynthesis Single source tomosynthesis is shown on the top left. Multi source tomosynthesis is shown on the bottom left. It shows a special scan protocol that is only possible with multi sources. https://twitter.com/i/web/status/1885691983072792935 https://twitter.com/i/web/status/1885691983072792935"
X Link 2025-02-01T14:09Z [---] followers, [----] engagements

"The $NNOX's significant achievement of $NANOX's three papers accepted at ECR (European Congress of Radiology) lies in the official validation that their 3D Tomosynthesis system demonstrated 90% radiation dose reduction compared to high-end CT while maintaining the capability to detect pulmonary nodules as small as 3mm in chest scanning. Global Leading Causes of Death and the Role of Early Detection in Public Health: Analysis Based on CDC and NIH Data Major Global Causes of Mortality: [--]. Cardiovascular Diseases (CVD) - Approximately [----] million deaths annually - Accounts for 32% of all-cause"
X Link 2025-02-11T13:53Z [---] followers, [----] engagements

"$NNOX's recent highlights and business analysis: [--]. Regulatory approval and commercialization progress - Expansion of actual deployment orders for $Nanox.ARC system with FDA cleared and CE approval imminent - In particular the integrated platform of ARC and AI solutions has entered the verification phase in actual medical fields - Improved accuracy of Deep Learning-based medical image analysis solution and accumulation of actual cases [--]. Strengthened cooperation with Nuance Communications (Microsoft) - Integration of voice recognition and automatic reporting system for medical image data -"
X Link 2025-02-14T14:25Z [---] followers, [----] engagements

"$Nanox s Q4 [----] results show $3.0 million in revenues and $14.1 million in net loss but more importantly regulatory successes include FDA and CE Marking. In particular the FDA 510(k) filing for $NNOX.ARC_X is expected to be a significant event for the companys future. Currently teleradiology services are the primary revenue source at $2.8 million but once Nanox.ARC X and 2D Synthetic-3D Tomosynthesis Mammography technology are commercialized it is likely to become a stable source of revenue (ATM). The expansion of additional clinical trials in Europe will accelerate the global"
X Link 2025-03-31T13:53Z [---] followers, [----] engagements

"## $NANOX s Most Urgent ISSUE to start revenue: From 3D tomosynthesis to standalone diagnostic device via 2D synthetic images - Nanox's multi-source by $NNOX Arc_X innovation ### [--]. Current 2D synthetic image generation technology Algorithm-based - Maximum Intensity Projection (MIP) transform compresses 3D voxel data into a 2D plane. - Iterative reconstruction minimizing global variation (TV) - TV2D: Independent slice processing - TV3D: Simultaneous volume processing - Filtered backprojection (FBP) with special filters Commercial implementations (10B US$ Revenues in 2024) - **Hologic"
X Link 2025-07-16T23:32Z [---] followers, [----] engagements

"$Nanox Market Opportunity Assessment Total Addressable Market(TAM) for Multi-Source Tomosynthesis $NNOX s Primary Opportunities by 3D-2D : Underserved Markets:60 million Americans served by Critical Access Hospitals Imaging Technology News 1300+ CAHs with limited imaging capabilities 44% of rural counties lack adequate imaging access Technology Gaps:Aging equipment (7-10 year replacement cycle) Limited 3D imaging in rural areas High maintenance costs for traditional systems Payment Model Alignment:CMS goal: All Medicare beneficiaries in value-based care by [----] Bundled payment models"
X Link 2025-07-17T12:52Z [---] followers, [----] engagements

"$NNOX IMAGING LTD " $Nanox " today announced that it will report its financial results for the quarter ended June [--] [----] before market open on Tuesday August [--] [----]. Erez Meltzer Chief Executive Officer and Acting Chairman andRan Daniel Chief Financial Officer will host a conference call to review these results and provide a business update beginning at8:30 a.m. ET. Interested parties may register for the conference call using the following link:Nanox Q2 [----] Conference Call. The live webcast of the conference call may be accessed by using the following link:Nanox Q2 [----] Webcast. The link"
X Link 2025-08-12T11:40Z [---] followers, [---] engagements

"$NNOX $NanoX Imaging 2Q [----] Earnings Release Q&A Session [--]. Ross Osborne (Cantor Fitzgerald) Question Q1: How many systems were in operation generating $221000 in imaging revenue during the quarter Answer (Erez Meltzer CEO): More than [--] systems are currently scanning patients. Some of the 60+ systems announced in the previous quarter are now operational. The number of systems in operation those in the pipeline and those in the pipeline are all growing exponentially. All [---] systems targeted for the end of the year have already been identified with installation and operational schedules"
X Link 2025-08-12T14:07Z [---] followers, [----] engagements

"$NNOX Arc_X Mass Production Analysis - Strategic Manufacturing Partnerships [--]. #Fabrinet Strategic Manufacturing Alliance Nano-X has executed a multi-year volume supply agreement with Fabrinet a premier global electronics manufacturing services provider to enable scaled production of the Nanox.ARC advanced imaging system. Key Provisions: Comprehensive manufacturing services encompassing assembly testing procurement and quality control Ensures reliable cost-effective delivery aligned with Nanox specifications Provides production flexibility and demand forecasting capabilities to support"
X Link 2025-08-12T15:56Z [---] followers, [----] engagements

"$NNOX still holds the WKSI - ATM Cash Counter option and is financially sound for the next [--] years"
X Link 2025-08-13T13:50Z [---] followers, [----] engagements

"## Investment Thesis on $NNOX - A Contrarian Perspective $NANOX In response to persistent skeptics who remain entrenched in their bearish narrative: Nano-X Imaging possesses unparalleled technological differentiation and market penetration capabilities addressing a $200 Billion global medical imaging equipment and diagnostics market. Both the CEO and CFO have articulated concrete timelines for traversing the "death valley" phase of commercialization. What the critics fail to comprehend is the paradigm shift potential inherent in this disruptive technology. Their myopic focus on"
X Link 2025-08-14T16:36Z [---] followers, [----] engagements

"The company is financially sound. $NNOX $NANOX The business has robust options to maintain multiple financial safeguards. -. There is no debt. -. They have a Cash ATM option. -. The company also utilizes an MSAAS beneficiary structure with Varex which accounts for a significant portion of its manufacturing costs. Despite the massive deployment expansion capital expenditures are kept to a minimum and the CFO affirmed that this year sales will mark a turning point in strengthening the company's financial position. https://twitter.com/i/web/status/1957844279696716146"
X Link 2025-08-19T16:37Z [---] followers, [----] engagements

"$NNOX Share holders We all expected revenues to begin in April [----] when MSK approval was granted by FDA and deployment would follow shortly thereafter. However sales remained elusive for a long time. Frustrated we dug deeper and discovered the truth. The first-ever Cold Cathode 3D technology was subjected to rigorous validation across a wide range of fields and faced numerous constraints that required perfection. Most of this was due to clinical trials and the validation of the source tube technology. This additional two-year timeline was a significant factor in causing distress to"
X Link 2025-08-30T11:40Z [---] followers, [----] engagements

"$NANOX IMAGING Q2 [----] Regulatory & Marketing $NNOX CEO Statement: "TAP2D submission aims to receive clearance for 2D view image output for the Nanox.ARC system a practical tool for radiologists to enhance their diagnostic confidence as they become more experienced evaluating BTS images." ## Importance of TAP2D Body Tomosynthesis & FDA TAP [---] Program ### 📋 Executive Brief 💡 CEO's Q2 [----] statement interpreted the TAP2D submission and Body Tomosynthesis (BTS) images as key regulatory initiatives for Nano-X's whole-body tomosynthesis market entry strategy and **resolving"
X Link 2025-09-15T09:36Z [---] followers, [----] engagements

"MHTGA (Trumpcare) Chronic Disease Early Detection Policy & $Nanox Business Strategy Alignment Strategic Relationship Analysis $NNOX 🟢 Policy Tailwinds CMS AI Policy Support: Aggressive AI utilization support during 2024-2026 Contract Years creating favorable regulatory environment for AI-enhanced diagnostic solutions MCED Legislative Advancement: Congressional progression of Multi-Cancer Early Detection coverage legislation establishing precedent for innovative screening technologies Established Reimbursement Framework: Tomosynthesis procedures eligible for Medicare reimbursement under"
X Link 2025-09-18T03:33Z [---] followers, [----] engagements

"$NNOX ArcX https://finance.yahoo.com/news/nanox-announces-multi-segment-healthcare-120000540.html https://finance.yahoo.com/news/nanox-announces-multi-segment-healthcare-120000540.html"
X Link 2025-09-19T07:00Z [---] followers, [----] engagements

"#RSNA25 Highlighting the "Sweet Spot" of $NNOX Arc_X Existing: DTS detection rate 32% -- Limited use $NANOX Multi-Source: DTS **Records sensitivity of 85% and specificity of 95% *Increases lung nodule detection while also *Can be incorporated into lung cancer screening program protocols. DTS's sensitivity and specificity are at the "sweet spot" for lung cancer screening: digital-tomosynthesis-may-aid-in-lung-cancer-screening A solution that effectively bridges the gap between CXR and CT. AI-integrated synergy AI-assisted detection rate increases by more than threefold Differentiation"
X Link 2025-10-02T11:20Z [---] followers, [----] engagements

"One of the two new advisory board members officially announced by the $NNOX CEO in Q2 ER along with a public health expert from Philips is the CTO of #RADNET the largest radiology imaging company in the US (RADNET generates over $400 million in annual net revenue). This is a prominent figure who will be presenting at RSNA on ARC_X + AI Pulmonary and MSK. https://aimi.stanford.edu/people/lawrence-tanenbaum https://aimi.stanford.edu/people/lawrence-tanenbaum https://aimi.stanford.edu/people/lawrence-tanenbaum https://aimi.stanford.edu/people/lawrence-tanenbaum"
X Link 2025-10-04T04:49Z [---] followers, [----] engagements

"Historical turning points are like the contrast between pitch-black darkness and dazzling light. Long-standing skepticism about new $NNOX s technologies inexperience with new $NANOX Arcs multi-source architectures rigorous and demanding technology validation processes durability and consistent quality price-effectiveness market penetration proof of concept and public validation of a business model that enters an existing market but is expanding the new market more than tenfold and evaluations by industry-leading Medical Imaging - AI experts in the RSNA Peer Review verification of diagnostic"
X Link 2025-10-09T01:50Z [---] followers, [----] engagements

"$NNOX $NANOX Arc-X Arc multi-source Tomosynthesis Finally Received a strong recommendation from a top-tier MD in the industry. https://youtu.be/QEUnZVH2YZAsi=NqWGol9Etfyv6aTm https://youtu.be/QEUnZVH2YZAsi=NqWGol9Etfyv6aTm"
X Link 2025-10-14T00:08Z [---] followers, [----] engagements

"🔍 RSNA IT2-IT102 $NNOX's muti source Complete Analysis $Nanox Arc DTS lung test results - Abstract detailed verification completed ✅ Abstract details confirmation completed "Nanox: Vision of Reality AI and Digital Tomogram Synthesis in Lung Nodule Detection" Data of 85% sensitivity and 95% specificity (5 mm lung nodules) were identified in the RSNA [----] IT2-IT102 official announcement. https://twitter.com/i/web/status/1978441576872337587 https://twitter.com/i/web/status/1978441576872337587"
X Link 2025-10-15T12:43Z [---] followers, [----] engagements

"RSNA [----] $NNOX Presentation Information Title: " $Nanox : From Vision to Reality AI and Digital Tomosynthesis in Pulmonary Nodule Detection""
X Link 2025-10-24T04:38Z [---] followers, [----] engagements

"$NNOX AI $NANOX Webinar https://www.youtube.com/watchv=zQriqj9nfwc https://www.youtube.com/watchv=zQriqj9nfwc"
X Link 2025-10-29T05:36Z [---] followers, [----] engagements

"#NANOX imaging Predicting the end of a short #CarsonBlock and #WallStreet's most vicious henchman in history #Richard_X_Roe Breaking through powerful all-out slander (#FDA insurance reimbursement companies investment institutions) $NNOX Arc enters to generates official revenues and #PoC stage. Mass production is also underway with Nasdaq's #Nvidia partner Parallel with #Fabrinet "
X Link 2025-10-30T03:26Z [---] followers, [---] engagements

"$Nanox: From Vision to Reality $NNOX AI and Digital Tomosynthesis in Pulmonary Nodule Detection https://cattendee.abstractsonline.com/meeting/21232/Session/815 https://cattendee.abstractsonline.com/meeting/21232/Session/815"
X Link 2025-11-18T08:16Z [---] followers, [----] engagements

"$NANOX $NNOX Just officially announced that [----] sales will be the combined sales of [----] + [----] + [----]. It seems the snowball is finally starting to roll"
X Link 2025-11-20T13:13Z [---] followers, [----] engagements

"$NANOX $NNOX Predictions made three years ago are only now beginning to materialize and have been confirmed by concrete statements from management. Stationary CT #MBX OEMs New Arc-X systems. AI ready 3D tomosynthesis. TAP 2D submission"
X Link 2025-11-20T15:28Z [---] followers, [---] engagements

"$NANOX $NNOX I've compiled management's Q3 outlook and fact-based analysis of sales to date into a simple visualization. I hope the graphs in this post provide some comfort to those who have been struggling for a long time. This assessment is firmly grounded in empirical evidence. https://twitter.com/i/web/status/1991789165365854451 https://twitter.com/i/web/status/1991789165365854451"
X Link 2025-11-21T08:41Z [---] followers, [----] engagements

"$NANOX $NNOX year27 forecast is based on the conversation between the CFO and the panel that participated in the 3Q ER that the current OpEx consumption and cumulative annual loss estimate will not change much even if the sales and revenue increase and the minimum sales to reach the quarterly BEP that the company claims is approximately $100-120M so the graph was created by taking the median of these. https://twitter.com/i/web/status/1991812795722346743 https://twitter.com/i/web/status/1991812795722346743"
X Link 2025-11-21T10:15Z [---] followers, [---] engagements

"Who is the entity behind this singular acquisition of $NANOX And why did they procure a stake exceeding 5% in $NNOX a stake that is undeniably conspicuous Having studied $Nanox in depth for a long time I'd like to offer my guess. -------------------------------- Holdings surpassing 5% necessitate disclosure within a 5-days timeframe. Schedule 13D/13G Disclosure Requirements (within [--] + [--] days) While additional particulars will be unveiled through an ensuing press release announcing the strategic alliance the transference of a significant stake at a preferential price under seemingly"
X Link 2025-11-24T10:21Z [---] followers, [----] engagements

"The prevailing focus surrounding $NNOX pertains to insider investments. Possessing exclusive insights not available to us enables them to execute pertinent strategies and interpret market trends effectively. Given that this $NANOX investment surpasses 5% the true orchestrator will soon be unveiled. In light of the current narrative I would place heightened importance on the potential involvement of #3DR and its proprietor #Arsenal Capital. If substantiated this undoubtedly represents the most substantial capital infusion by a strategic investor at this juncture. Moreover as they capitalize on"
X Link 2025-11-24T11:09Z [---] followers, [----] engagements

"$NNOX ArcX + AI $NANOX https://youtu.be/ZJ0ROgfNwPofeature=shared https://youtu.be/CoOZqWsXhXcfeature=shared https://youtu.be/ZJ0ROgfNwPofeature=shared https://youtu.be/CoOZqWsXhXcfeature=shared"
X Link 2025-11-25T14:53Z [---] followers, [---] engagements

"$NNOX Arc's EU standalone approval serves as a leading indicator of the #FDA standalone transition and $NANOX Arc-X is structured to follow that path. Sources: 3q ER updated transscript Press Release - official https://twitter.com/i/web/status/1993530306260091360 https://twitter.com/i/web/status/1993530306260091360"
X Link 2025-11-26T04:00Z [---] followers, [----] engagements

"$Nanox Expert Testimonials 1: Bogdan Radu Niculescu Profile: CEO MEDIST Romania Medical Imaging Distribution Leader Key Insights: Arc delivers superior image quality + exceptional reliability + lower operational costs Integrated tomosynthesis reconstructs multi-angle images into detailed cross-sectional views Low radiation dose enables early detection & reduces false positives Verdict: " $NNOX represents a transformative step in medical imaginga true GAME CHANGER." 2: Jay Patel Profile: Founder & President Salinas Valley Advanced Imaging Center Early Adopter Key Insights: Open welcoming"
X Link 2025-11-26T10:16Z [---] followers, [----] engagements

"$NANOX Imaging: The Inflection Point That Value Investors Keep Missing The #DanielJoness Framework Problem. Daniel Jones runs "Crude Value Insights" for $NNOX a cash-flow focused newsletter for oil and gas investors. His analytical rigor is well-suited to mature capital-intensive businesses with predictable cash generation. This is the wrong tool for evaluating medical device companies at commercial inflection points. By his framework Intuitive Surgical in [----] DexCom in [----] and Shockwave Medical in [----] were all "uninvestable." Each delivered 10x+ returns to investors who recognized"
X Link 2025-11-28T01:50Z [---] followers, [----] engagements

"$NNOX $NANOX Is it game changer Is it Right Journey to the AI Ready to AI intergrated. https://t.co/6cD5ZnFt8j $Nanox Expert Testimonials 1: Bogdan Radu Niculescu Profile: CEO MEDIST Romania Medical Imaging Distribution Leader Key Insights: Arc delivers superior image quality + exceptional reliability + lower operational costs Integrated tomosynthesis https://t.co/6cD5ZnFt8j $Nanox Expert Testimonials 1: Bogdan Radu Niculescu Profile: CEO MEDIST Romania Medical Imaging Distribution Leader Key Insights: Arc delivers superior image quality + exceptional reliability + lower operational costs"
X Link 2025-11-28T09:33Z [---] followers, [----] engagements

"$NANOX deployment in France $NNOX 3D tomosynthesis. #Arc Under the terms of the engagement Althea France will lead the market introduction sales and service of Nanoxs medical imaging solution theNanox.ARC a multi-source digital tomosynthesis system that utilizes advanced 3D imaging technology to provide enhanced diagnostic capabilities at a lower cost than traditional systems. Following itsCE Mark certification the Nanox.ARC is cleared for commercialization across the European Union. https://www.althea-group.com/fr/blog/2025/11/25/nanox_althea_france/"
X Link 2025-11-28T23:41Z [---] followers, [----] engagements

"$NANOX $NNOX"
X Link 2025-12-01T06:22Z [---] followers, [---] engagements

"$NNOX Arc_X Assessment: Conditionally Suitable Screening Lung cancers. From a resolution standpoint $NANOX Arc_X the 1.0mm slice interval meets the technical requirements for lung cancer screening. It satisfies the 1.5mm slice thickness criteria recommended by LDCT guidelines (Lung-RADS) and provides theoretically sufficient resolution for detecting clinically significant pulmonary nodules 4mm. https://twitter.com/i/web/status/1995381586536304697 https://twitter.com/i/web/status/1995381586536304697"
X Link 2025-12-01T06:36Z [---] followers, [----] engagements

"$Nanox.ARC $NNOX Cold cathode emitter enveloped by #Varex Imaging"
X Link 2025-12-02T00:31Z [---] followers, [---] engagements

"$Nanox.ARC Exclusive Parametership in West Balkan. $NNOX https://www.globenewswire.com/news-release/2026/01/14/3218609/0/en/Nanox-Expands-in-Europe-with-New-Nanox-ARC-Distribution-Engagement-in-Serbia-Montenegro-and-Bosnia-and-Herzegovina.html https://www.globenewswire.com/news-release/2026/01/14/3218609/0/en/Nanox-Expands-in-Europe-with-New-Nanox-ARC-Distribution-Engagement-in-Serbia-Montenegro-and-Bosnia-and-Herzegovina.html"
X Link 2026-01-14T14:08Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing